JP2007531757A5 - - Google Patents

Download PDF

Info

Publication number
JP2007531757A5
JP2007531757A5 JP2007506511A JP2007506511A JP2007531757A5 JP 2007531757 A5 JP2007531757 A5 JP 2007531757A5 JP 2007506511 A JP2007506511 A JP 2007506511A JP 2007506511 A JP2007506511 A JP 2007506511A JP 2007531757 A5 JP2007531757 A5 JP 2007531757A5
Authority
JP
Japan
Prior art keywords
carboxamide
thiophene
pyrimidin
methylamino
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007506511A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007531757A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/010690 external-priority patent/WO2005095386A1/en
Publication of JP2007531757A publication Critical patent/JP2007531757A/ja
Publication of JP2007531757A5 publication Critical patent/JP2007531757A5/ja
Pending legal-status Critical Current

Links

JP2007506511A 2004-03-30 2005-03-30 抗癌剤としての置換チオフェン誘導体 Pending JP2007531757A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55834204P 2004-03-30 2004-03-30
PCT/US2005/010690 WO2005095386A1 (en) 2004-03-30 2005-03-30 Substituted thiophene derivatives as anti-cancer agents

Publications (2)

Publication Number Publication Date
JP2007531757A JP2007531757A (ja) 2007-11-08
JP2007531757A5 true JP2007531757A5 (https=) 2008-04-17

Family

ID=34972501

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007506511A Pending JP2007531757A (ja) 2004-03-30 2005-03-30 抗癌剤としての置換チオフェン誘導体

Country Status (11)

Country Link
US (2) US7470701B2 (https=)
EP (1) EP1732919A1 (https=)
JP (1) JP2007531757A (https=)
CN (1) CN1989131A (https=)
AU (1) AU2005228899A1 (https=)
BR (1) BRPI0508230A (https=)
CA (1) CA2561977A1 (https=)
IL (1) IL177799A0 (https=)
MX (1) MXPA06010520A (https=)
RU (1) RU2006138036A (https=)
WO (1) WO2005095386A1 (https=)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8329924B2 (en) * 2001-06-11 2012-12-11 Vertex Pharmaceuticals (Canada) Incorporated Compounds and methods for the treatment or prevention of Flavivirus infections
CN101624391A (zh) * 2001-06-11 2010-01-13 病毒化学医药公司 用作黄病毒感染抗病毒剂的噻吩衍生物
US7402608B2 (en) * 2002-12-10 2008-07-22 Virochem Pharma Inc. Compounds and methods for the treatment or prevention of Flavivirus infections
TW200533357A (en) * 2004-01-08 2005-10-16 Millennium Pharm Inc 2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases
US20080293716A1 (en) * 2004-01-30 2008-11-27 Smithkline Beecham Corporation Chemical Compounds
EP1907385A4 (en) * 2005-07-26 2009-05-06 Smithkline Beecham Corp LINKS
WO2007016292A2 (en) * 2005-07-27 2007-02-08 Vertex Pharmaceuticals Incorporated Heterocyclic amides as biofilm modulators
US7803806B2 (en) 2005-11-03 2010-09-28 Sgx Pharmaceuticals, Inc. Pyrimidinyl-thiophene kinase modulators
MY149143A (en) * 2006-01-18 2013-07-15 Amgen Inc Thiazole compounds as protien kinase b (pkb) inhibitors
AU2007208358A1 (en) 2006-01-23 2007-08-02 Vertex Pharmaceuticals Incorporated Thiophene-carboxamides useful as inhibitors of protein kinases
ZA200808966B (en) * 2006-03-27 2010-03-31 Nerviano Medical Sciences Srl Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
EP2418210A1 (en) * 2006-04-13 2012-02-15 Vertex Pharmceuticals Incorporated Thiophene-carboxamides useful as inhibitors of protein kinases
AU2007268056A1 (en) 2006-05-23 2007-12-06 Vertex Pharmaceuticals Incorporated Thiophene-carboxamides useful as inhibitors of protein kinases
JP2009538309A (ja) 2006-05-23 2009-11-05 バーテックス ファーマシューティカルズ インコーポレイテッド プロテインキナーゼのインヒビターとして有用なチオフェンカルボキサミド
CA2670260A1 (en) 2006-11-15 2008-05-22 Virochem Pharma Inc. Thiophene analogues for the treatment or prevention of flavivirus infections
UY30892A1 (es) 2007-02-07 2008-09-02 Smithkline Beckman Corp Inhibidores de la actividad akt
AU2012233017B2 (en) * 2007-02-07 2013-01-10 Novartis Ag Inhibitors of Akt activity
WO2008098105A1 (en) * 2007-02-07 2008-08-14 Smithkline Beecham Corporation Inhibitors of akt activity
DE102007010801A1 (de) 2007-03-02 2008-09-04 Bayer Cropscience Ag Diaminopyrimidine als Fungizide
AU2008276512A1 (en) * 2007-07-17 2009-01-22 Amgen Inc. Thiadiazole modulators of PKB
US7897619B2 (en) 2007-07-17 2011-03-01 Amgen Inc. Heterocyclic modulators of PKB
RS54303B1 (sr) 2007-07-19 2016-02-29 Lundbeck, H., A/S 5-člani heterociklični amidi i srodna jedinjenja
PL2201012T3 (pl) * 2007-10-11 2014-11-28 Astrazeneca Ab Pochodne pirolo[2,3-d]pirymidyny jako inhibitory kinazy białkowej b
JP5581219B2 (ja) 2008-01-25 2014-08-27 ミレニアム ファーマシューティカルズ, インコーポレイテッド チオフェンおよびホスファチジルイノシトール3−キナーゼ(pi3k)阻害薬としてのその使用
TWI426074B (zh) * 2008-04-30 2014-02-11 Nerviano Medical Sciences Srl 5-(2-胺基-嘧啶-4-基)-2-芳基-1h-吡咯-3-羧醯胺之製造方法
JP2011525930A (ja) * 2008-06-26 2011-09-29 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー Akt活性の阻害剤
EP2303852A4 (en) * 2008-06-26 2011-12-28 Glaxosmithkline Llc ACTIVITY INHIBITORS AKT
EP2161259A1 (de) 2008-09-03 2010-03-10 Bayer CropScience AG 4-Halogenalkylsubstituierte Diaminopyrimidine als Fungizide
US9090601B2 (en) 2009-01-30 2015-07-28 Millennium Pharmaceuticals, Inc. Thiazole derivatives
US8796314B2 (en) 2009-01-30 2014-08-05 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
US20110288142A1 (en) 2009-01-30 2011-11-24 Chen Pingyun Y CRYSTALLINE N--5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
WO2010090716A1 (en) 2009-01-30 2010-08-12 Millennium Pharmaceuticals, Inc. Heteroaryls and their use as pi3k inhibitors
EP2403857B1 (en) 2009-03-05 2013-12-04 Takeda Pharmaceutical Company Limited Thienopyrimidine as cdc7 kinase inhibitors
WO2011011303A1 (en) 2009-07-21 2011-01-27 Gilead Sciences, Inc. Inhibitors of flaviviridae viruses
ES2559437T3 (es) 2009-09-09 2016-02-12 Gilead Sciences, Inc. Inhibidores de virus de la familia Flaviviridae
AP3576A (en) 2010-01-15 2016-02-08 Gilead Sciences Inc Inhibitors of flaviviridae viruses
CA2785563C (en) 2010-01-15 2019-05-14 Gilead Sciences, Inc. Inhibitors of flaviviridae viruses
NZ602089A (en) 2010-02-17 2014-05-30 Takeda Pharmaceutical Heterocyclic compounds having cell division cycle 7 inhibitory activity
US8859768B2 (en) 2010-08-11 2014-10-14 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
MX2013001660A (es) 2010-08-11 2013-06-03 Millenium Pharmaceuticals Inc Heteroarilos y usos de los mismos.
WO2012021611A1 (en) 2010-08-11 2012-02-16 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
TW201307309A (zh) 2010-10-13 2013-02-16 Millennium Pharm Inc 雜芳基化合物及其用途
AU2012280959B2 (en) 2011-07-13 2015-08-06 Gilead Sciences, Inc. Thiophen-2-carboxylic acid derivatives useful as inhibitors of Flaviviridae viruses
TWI490221B (zh) * 2011-08-15 2015-07-01 Takeda Pharmaceutical 雜環化合物
PT3184523T (pt) * 2012-04-13 2019-09-26 Eisai R&D Man Co Ltd Bromidrato de n-((4,6-dimetil-2-oxo-l,2-di-hidropiridin- 3-il)metil)-5-(etil(tetra-hidro-2h-piran-4-il)amino)-4- metil-4¿-(morfolinometil)-[l,1¿-bofenil]-3-carboxamida para utilização no tratamento de uma doença proliferativa celular do sistema hematológico
WO2013161871A1 (ja) * 2012-04-25 2013-10-31 興和株式会社 Tlr阻害作用を有するチオフェン誘導体
US8759544B2 (en) 2012-08-17 2014-06-24 Gilead Sciences, Inc. Synthesis of an antiviral compound
US8927741B2 (en) 2012-08-17 2015-01-06 Gilead Sciences, Inc. Synthesis of an antiviral compound
US8841340B2 (en) 2012-08-17 2014-09-23 Gilead Sciences, Inc. Solid forms of an antiviral compound
EP2991980B1 (en) * 2013-04-30 2019-01-02 Glaxosmithkline Intellectual Property (No. 2) Limited Enhancer of zeste homolog 2 inhibitors
CN104262289B (zh) * 2014-10-09 2016-06-08 武汉大学 一种苯并噻唑衍生物及其抗肿瘤用途
LT3319959T (lt) 2015-07-06 2021-12-27 Alkermes, Inc. Histono deacetilazės hetero-halogeno inhibitoriai
EP3319968A1 (en) 2015-07-06 2018-05-16 Rodin Therapeutics, Inc. Heterobicyclic n-aminophenyl-amides as inhibitors of histone deacetylase
KR102650026B1 (ko) * 2015-09-18 2024-03-22 메르크 파텐트 게엠베하 Irak 억제제로서의 헤테로아릴 화합물 및 이의 용도
WO2017063966A1 (en) * 2015-10-13 2017-04-20 Bayer Pharma Aktiengesellschaft Substituted 2-(1h-pyrazol-1-yl)-benzothiazole compounds
EP3388428B1 (en) * 2015-12-07 2021-08-04 Suzhou Sinovent Pharmaceuticals Company Five-membered heterocyclic amides wnt pathway inhibitor
CN108884066B (zh) 2016-02-16 2021-08-24 韩国科学技术研究院 作为蛋白激酶抑制剂的2,3,5-取代的噻吩化合物
RS62959B1 (sr) 2017-01-11 2022-03-31 Alkermes Inc Biciklični inhibitori histon-deacetilaze
GB201712567D0 (en) 2017-08-04 2017-09-20 Karin & Sten Mortstedt Cbd Solutions Ab Selective ligands for tau aggregates
US11225475B2 (en) 2017-08-07 2022-01-18 Alkermes, Inc. Substituted pyridines as inhibitors of histone deacetylase
GB201807147D0 (en) 2018-05-01 2018-06-13 Oncologica Uk Ltd Therapeutic combination
CN109400595B (zh) * 2018-12-24 2020-07-17 深圳市第二人民医院 一类含噻吩环的抗癌化合物
CA3131930A1 (en) * 2019-02-28 2020-09-03 Kezar Life Sciences Thiazole derivatives as protein secretion inhibitors
US20220389026A1 (en) * 2019-08-20 2022-12-08 Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Tetracyclic compound used as cdc7 inhibitor
CN115536648B (zh) * 2021-06-29 2024-09-17 深圳开悦生命科技有限公司 一类抑制rna解旋酶dhx33的多环化合物及其应用
CN114644582B (zh) * 2022-04-11 2024-03-29 中原工学院 一种苯基双硫脲类化合物的制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3908012A (en) * 1970-10-05 1975-09-23 Pfizer Arylpyrimidines-inhibitors of platelet aggregation and bronchodilators
US6034093A (en) * 1995-06-07 2000-03-07 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds
US5731315A (en) * 1995-06-07 1998-03-24 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted sulfonic acid n- (aminoiminomethyl)phenylalkyl!-azaheterocyclamide compounds
US6080767A (en) * 1996-01-02 2000-06-27 Aventis Pharmaceuticals Products Inc. Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
CA2338697A1 (en) * 1998-07-28 2000-02-10 Smithkline Beecham Corporation Compounds and methods
WO2000075129A1 (en) 1999-06-07 2000-12-14 Shire Biochem Inc. Thiophene integrin inhibitors
JP4064671B2 (ja) 2000-02-25 2008-03-19 エフ.ホフマン−ラ ロシュ アーゲー アデノシン受容体モジュレーター
JP2002037784A (ja) * 2000-05-17 2002-02-06 Nikken Chem Co Ltd 新規チオフェンアミド化合物
DE10034623A1 (de) * 2000-07-17 2002-01-31 Bayer Ag Heterocyclisch substituierte Pyridine als Cytokin-Inhibitoren
MXPA03009378A (es) * 2001-04-13 2004-01-29 Vertex Pharma Inhibidores de cinasas c-jun n-terminales (jnk) y otras proteinas cinasas.
SE0102439D0 (sv) * 2001-07-05 2001-07-05 Astrazeneca Ab New compounds
FR2827603B1 (fr) 2001-07-18 2003-10-17 Oreal Composes derives de diaminopyrazole substitues par un radical heteroaromatique et leur utilisation en teinture d'oxydation des fibres keratiniques
US6897220B2 (en) * 2001-09-14 2005-05-24 Methylgene, Inc. Inhibitors of histone deacetylase
AU2002356871A1 (en) * 2001-10-30 2003-05-12 Pharmacia Corporation Heteroaromatic carboxamide derivatives for the treatment of inflammation
EP1494675A4 (en) * 2002-04-08 2006-07-19 Merck & Co Inc HEMMER OF ACT ACTIVITY
GB0209715D0 (en) * 2002-04-27 2002-06-05 Astrazeneca Ab Chemical compounds
US7119111B2 (en) * 2002-05-29 2006-10-10 Amgen, Inc. 2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use
GB0215650D0 (en) * 2002-07-05 2002-08-14 Cyclacel Ltd Bisarylsufonamide compounds
PL374970A1 (en) * 2002-08-02 2005-11-14 Argenta Discovery Limited Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors
EP1558607B1 (en) * 2002-10-30 2010-05-05 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of rock and other protein kinases
CA2517256C (en) * 2003-02-26 2013-04-30 Sugen, Inc. Aminoheteroaryl compounds as protein kinase inhibitors
GB0308466D0 (en) * 2003-04-11 2003-05-21 Novartis Ag Organic compounds
TW200533357A (en) * 2004-01-08 2005-10-16 Millennium Pharm Inc 2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases
US20080293716A1 (en) * 2004-01-30 2008-11-27 Smithkline Beecham Corporation Chemical Compounds

Similar Documents

Publication Publication Date Title
JP2007531757A5 (https=)
RU2006138036A (ru) Производные замещенного тиофена в качестве противораковых средств
AU2005316312B2 (en) Aminopyrimidine compounds and methods of use
RU2009149696A (ru) 5-замещенные индазолы в качестве ингибиторов киназы
JP2017538750A5 (https=)
RU2010137300A (ru) Модуляторы бета-амилоида
RU2010137114A (ru) Амидные производные как позитивные аллостерические модуляторы и способы их применения
JP2007516173A5 (https=)
RU2017125520A (ru) Соединения, ингибирующие parg
RU2008141510A (ru) Новые соединения
HRP20211960T1 (hr) Alosterični modulatori nikotinskih acetilcolinskih receptora
RU2017139727A (ru) Гетероциклические ингибиторы erk1 и erk2 и их применение для лечения злокачественного новообразования
RU2006145205A (ru) Терапевтические соединения: пиридин в качестве каркаса
ME00681B (me) Jedinjenje indola
RU2019117958A (ru) Производные индола, полезные в качестве ингибиторов диацилглицерид-о-ацилтрансферазы 2
JP2013516415A5 (https=)
JP2004509952A5 (https=)
RU2007138978A (ru) Гетероциклическое соединение
JP2005527625A5 (https=)
ZA200400347B (en) Aminoisoxazole derivatives active as kinase inhibitors
CN1503786A (zh) 高传导率钙-活化k通道开启剂
JP2013538801A5 (https=)
JP2016523963A5 (https=)
RU2007143966A (ru) Конденсированные гетероциклические соединения
RU2011103789A (ru) Производное триазола или его соль